|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
How to Implement Incretin Therapy
|
|
|
The roles of glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors are rapidly evolving, despite limited recommendations on their use in current guidelines.
|
| 2. |
Comorbidity Erodes Benefits of Tight Glucose Control in Elderly
|
|
|
In elderly type 2 diabetics with comorbid illness or functional impairment, the benefit of intensive glucose control to a maximum hemoglobin A1c of 7% (versus moderate control to HbA1c 7.9%) appears to be only modest, according to research reported in the July 1st issue of the Annals of Internal Medicine. Reuters Health Information
|
| 3. |
Long-Term A1c Stability Reduces Risk of Diabetic Retinopathy, Nephropathy
|
|
|
Results from the long-term Diabetes Control and Complications Trial (DCCT) "suggest that long term stability of glucose control is a factor in reducing the risk of the small vessel complications of type 1 diabetes," one of the principal investigators tells Reuters Health. Reuters Health Information
|
|
|
